HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zoltán Széplaki Selected Research

Ischemic Stroke

12/2011Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke.
5/2009Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.
7/2007Estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms in ischemic stroke in a Hungarian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zoltán Széplaki Research Topics

Disease

3Ischemic Stroke
12/2011 - 07/2007
2Atherosclerosis
05/2008 - 07/2007
2Stroke (Strokes)
07/2007 - 01/2006
1Cerebral Infarction
12/2011
1Vascular Diseases (Vascular Disease)
05/2008
1Hereditary Angioedemas
05/2008
1Lacunar Stroke
01/2006

Drug/Important Bio-Agent (IBA)

2Complement System Proteins (Complement)IBA
12/2011 - 05/2009
1LectinsIBA
12/2011
1FicolinsIBA
12/2011
1Indicators and Reagents (Reagents)IBA
12/2011
1LDL CholesterolIBA
05/2008
1LDL Lipoproteins (beta Lipoproteins)IBA
05/2008
1HDL LipoproteinsIBA
05/2008
1Danazol (Azol)FDA LinkGeneric
05/2008
1danaparoid (Orgaran)FDA Link
07/2007
1Estrogen Receptor alphaIBA
07/2007
1CytokinesIBA
01/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006

Therapy/Procedure

1Therapeutics
05/2009